北美关节疼痛注射市场预测至 2028 年 - COVID-19 影响和药物（透明质酸、皮质类固醇等）、关节类型（膝、足和踝、肩和肘、髋等）和分布的区域分析渠道（零售药店、医院药店等）
No. of Pages: 126 | Report Code: TIPRE00024545 | Category: Life Sciences
No. of Pages: 126 | Report Code: TIPRE00024545 | Category: Life Sciences
北美关节止痛注射剂市场
< Span> 高度分散的市场，存在大量区域和本地参与者，为投资该市场领域的公司提供众多解决方案。公司提供的透明质酸注射剂通常用于治疗运动损伤，因为它们有助于缓解疼痛、减少炎症和改善关节功能。皮质类固醇也用于治疗与运动相关的损伤。运动损伤是由于直接撞击或施加大于身体部位可承受的力而引起的。最常见的运动损伤是扭伤、拉伤、关节损伤和擦伤。根据国家安全委员会 (NSC) 的数据，2019 年，美国因运动造成的伤害约为 468,000 起，是所有体育和娱乐类别中受伤人数最多的。参与足球、骑自行车、篮球、操场和足球活动的人是当年急诊科 (ED) 就诊人数最多的人。它还指出，运动损伤影响着成千上万从事各种运动的青少年。在北美，尤其是美国，COVID-19 病例数量出现了前所未有的增长，这导致包括关节疼痛注射剂在内的各种医疗保健产品的多项业务运营和制造活动停止，这对关节疼痛注射剂市场产生了负面影响。为了控制疫情，政府采取了预防措施，包括全面封锁和社会疏远政策。此外，医疗器械行业也面临着此次疫情的负面影响。随着 COVID-19 大流行的持续蔓延，医疗器械公司在管理运营方面遇到了困难。取消择期手术以减少医院和重症监护病房手术室中对 COVID-19 的接触，也对关节疼痛注射市场的增长产生了负面影响。然而，第二季度末，美国政府取消了对骨科手术的限制，患者也被允许前往骨科诊所就诊。这些决策帮助市场参与者挽回了疫情期间的损失。
北美关节痛注射剂市场预计将从2021年的27.8542亿美元增长到2028年的50.1047亿美元；预计 2021 年至 2028 年复合年增长率为 8.7%。北美国家正在成为制药和生物制药行业有吸引力的外包地点。蓬勃发展的国内医药市场和不断增加的在研药品数量进一步为该地区的合同制造商和仿制药生产开辟了新的途径。此外，为了满足不断增长的需求，许多合同组织正在扩大其制造能力。因此，新兴市场为制药企业带来了巨大的潜力和巨大的创收机会。根据美国卫生部发布的一份报告2018年人类服务部表示，美国每年进行近70万例膝关节置换手术。预计到2030年，每年手术数量可能达到约348万例。除了膝关节手术外，在老龄化人口中，髋关节置换手术的发生率也在增加。根据医疗保健研究和质量局的数据，美国每年进行超过 450,000 例全髋关节置换术。此外，根据《风湿病学杂志》2018 年发表的报告，美国全髋关节置换手术的发生率预计到 2030 年将增加 129%，即约 85 万例置换手术，到 2040 年将增加 284%，即约 1,429,000 个替换件。进步在于技术减少了手术时间。
按药品分，2020年北美关节痛注射剂市场中皮质类固醇细分市场份额最大。按关节类型分，膝关节细分市场占北美关节痛注射剂市场最大份额2020年。从分销渠道来看，医院药房细分市场在2020年北美关节止痛注射剂市场中占据最大份额。
准备本北美关节疼痛注射市场报告时提到的一些主要一手和二手来源是公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括中外制药株式会社；生物文图斯公司； Fidia Pharma 美国公司；屈曲治疗公司；生化学株式会社；辉凌有限公司；赛诺菲；阿尼卡治疗公司； OrthogenRx, Inc. 和 Teva Pharmaceutical Industries Ltd.
Strategic insights for North America Joint Pain Injection involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 2,785.42 Million |
| Market Size by 2028 | US$ 5,010.47 Million |
| Global CAGR (2021 - 2028) | 8.7% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 药物
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Joint Pain Injection refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Joint Pain Injection Market is valued at US$ 2,785.42 Million in 2021, it is projected to reach US$ 5,010.47 Million by 2028.
As per our report North America Joint Pain Injection Market, the market size is valued at US$ 2,785.42 Million in 2021, projecting it to reach US$ 5,010.47 Million by 2028. This translates to a CAGR of approximately 8.7% during the forecast period.
The North America Joint Pain Injection Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Joint Pain Injection Market report:
The North America Joint Pain Injection Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Joint Pain Injection Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Joint Pain Injection Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Joint Pain Injection Market
